GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 35 filers reported holding GLAXOSMITHKLINE PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,510,000 | +2.5% | 57,657 | +6.2% | 0.10% | +7.1% |
| Q1 2022 | $2,449,000 | +51.6% | 54,275 | +48.2% | 0.10% | +75.0% |
| Q4 2021 | $1,615,000 | +41.4% | 36,620 | +22.5% | 0.06% | +24.4% |
| Q3 2021 | $1,142,000 | +3.4% | 29,882 | +7.8% | 0.04% | +4.7% |
| Q2 2021 | $1,104,000 | +32.9% | 27,729 | +19.2% | 0.04% | +19.4% |
| Q1 2021 | $831,000 | +8.2% | 23,271 | +11.6% | 0.04% | 0.0% |
| Q4 2020 | $768,000 | -3.2% | 20,857 | -1.0% | 0.04% | -16.3% |
| Q3 2020 | $793,000 | -8.2% | 21,072 | -0.6% | 0.04% | -17.3% |
| Q2 2020 | $864,000 | +1.1% | 21,191 | -6.1% | 0.05% | -17.5% |
| Q1 2020 | $855,000 | -8.8% | 22,567 | +13.1% | 0.06% | +14.5% |
| Q4 2019 | $938,000 | +44.8% | 19,961 | +31.5% | 0.06% | +34.1% |
| Q3 2019 | $648,000 | +3.2% | 15,176 | -3.3% | 0.04% | +2.5% |
| Q2 2019 | $628,000 | +3.8% | 15,698 | +8.4% | 0.04% | +2.6% |
| Q1 2019 | $605,000 | +38.4% | 14,480 | +26.6% | 0.04% | +30.0% |
| Q4 2018 | $437,000 | +60.1% | 11,439 | +68.5% | 0.03% | +76.5% |
| Q3 2018 | $273,000 | -1.1% | 6,789 | +0.0% | 0.02% | -26.1% |
| Q3 2017 | $276,000 | +21.6% | 6,787 | +28.7% | 0.02% | +15.0% |
| Q2 2017 | $227,000 | -20.1% | 5,273 | -21.7% | 0.02% | -16.7% |
| Q1 2017 | $284,000 | -1.4% | 6,733 | -9.9% | 0.02% | -7.7% |
| Q4 2016 | $288,000 | -15.0% | 7,474 | -4.9% | 0.03% | -18.8% |
| Q3 2016 | $339,000 | +1.8% | 7,862 | +2.4% | 0.03% | -8.6% |
| Q2 2016 | $333,000 | +2.5% | 7,676 | -4.2% | 0.04% | -10.3% |
| Q1 2016 | $325,000 | -0.3% | 8,010 | -0.8% | 0.04% | +21.9% |
| Q4 2015 | $326,000 | -6.9% | 8,075 | -11.3% | 0.03% | -36.0% |
| Q3 2015 | $350,000 | +5.1% | 9,102 | +13.8% | 0.05% | +51.5% |
| Q2 2015 | $333,000 | -24.1% | 8,000 | -15.8% | 0.03% | -23.3% |
| Q1 2015 | $439,000 | +5.8% | 9,503 | -2.1% | 0.04% | +2.4% |
| Q4 2014 | $415,000 | -12.1% | 9,706 | -5.5% | 0.04% | -17.6% |
| Q3 2014 | $472,000 | -27.3% | 10,272 | -15.4% | 0.05% | -26.1% |
| Q2 2014 | $649,000 | +4.5% | 12,143 | +4.5% | 0.07% | -1.4% |
| Q1 2014 | $621,000 | -1.4% | 11,623 | -1.5% | 0.07% | -6.7% |
| Q4 2013 | $630,000 | -4.5% | 11,802 | -10.3% | 0.08% | -14.8% |
| Q3 2013 | $660,000 | +14.4% | 13,151 | +13.9% | 0.09% | -1.1% |
| Q2 2013 | $577,000 | – | 11,551 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |